Cargando…
Therapeutic Antibodies for the Treatment of Pancreatic Cancer
Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
TheScientificWorldJOURNAL
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925140/ https://www.ncbi.nlm.nih.gov/pubmed/20563534 http://dx.doi.org/10.1100/tsw.2010.103 |